Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07783061 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT07783061 · ClinicalTrials.gov record · last posted 2026-08-24

Reducing Cardiovascular Risks: The Role of Alcohol Use

StatusNot Yet Recruiting
PhaseNot applicable
Started2026-10
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
The purpose of this study is to learn whether avoiding alcohol can improve heart and blood vessel health in adults who regularly drink alcohol and have high blood pressure. High blood pressure is a major risk factor for cardiovascular disease (CVD), including heart attack and stroke. In this randomized, controlled trial, men and women aged 26 to 49 years who regularly consume alcohol and have high blood pressure will be assigned by chance to either stop drinking alcohol or continue their usual drinking habits for 8 weeks. Researchers will compare changes in blood pressure and other cardiovascular disease risk factors between the two groups. The information gained from this study may help researchers and health care providers better understand the effects of alcohol consumption on cardiovascular health and whether alcohol abstinence can reduce heart disease risk, especially in adults with high blood pressure.
Trial Details
NCT Number NCT07783061
Lead Sponsor The University of Texas at Arlington
Conditions Alcohol Drinking, Drinking Behavior, At-risk Drinking, Cardiovascular Risk Factor, High Blood Pressure
Enrollment 148 participants
Start Date 2026-10
Primary Completion 2031-08 (estimated)
Study Completion 2031-09 (estimated)
Updated on ClinicalTrials.gov 2026-08-24